China Universal Asset Management Company’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

China Universal Asset Management Company’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$34.8K	Sell	17,864 -2,055	-10%	-$4.19K	﹤0.01%	477
2026 Q1	$49K	Buy	19,919 +2,979	+18%	+$9.97K	﹤0.01%	459
2025 Q4	$67.4K	Buy	+16,940	New	+$75K	0.01%	435
2023 Q4	–	Sell	-1,789	Closed	-$2.36K	–	454
2023 Q3	$2.36K	Buy	1,789 +886	+98%	+$1.95K	﹤0.01%	425
2023 Q2	$2.7K	Sell	903 -22	-2%	-$71	﹤0.01%	411
2023 Q1	$3.2K	Buy	925 +372	+67%	+$1.8K	﹤0.01%	408
2022 Q4	$2.31K	Buy	553 +56	+11%	+$212	﹤0.01%	361
2022 Q3	$2K	Buy	+497	New	+$3.77K	﹤0.01%	349

Other funds holding NBP

ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

FCH

Freestone Capital Holdings Seattle, Washington $3.86B AUM 26.3% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

China Universal Asset Management Company's NBP Position: Q2 2026 in Review

China Universal Asset Management Company reduced its NovaBridge Biosciences American Depositary Shares (NBP) stake by 10% in Q2 2026, selling an estimated $4.19K and leaving 17,864 shares worth $34.8K. The position accounts for ﹤0.01% of the portfolio, ranked #477.

China Universal Asset Management Company first reported a position in NBP in Q3 2022 and has held it in 8 quarters since. The position peaked at $67.4K in Q4 2025. 6 funds tracked by Wall St. Rank hold NBP as of Q2 2026.

China Universal Asset Management Company held 17,864 shares of NovaBridge Biosciences American Depositary Shares worth $34.8K as of Q2 2026.
China Universal Asset Management Company sold 2,055 NovaBridge Biosciences American Depositary Shares shares in Q2 2026, an estimated $4.19K.
NovaBridge Biosciences American Depositary Shares made up ﹤0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #477 holding.
China Universal Asset Management Company first reported a position in NovaBridge Biosciences American Depositary Shares in Q3 2022 and has held it in 8 quarters since.
China Universal Asset Management Company's NovaBridge Biosciences American Depositary Shares position peaked at $67.4K in Q4 2025.
6 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.